This section provides a list of policy briefs based on the latest infectious disease studies by RITM researchers.
These policy briefs are concise summaries of analysis of current tropical and infectious disease data, along with recommendations directed at government policymakers. Each document contains a description of the recommended policy with evidences of the nature of the problem. This follows potential barriers, recommended plan and implementation strategies, and ultimately, the impact and benefits of taking these health policies into action.
Insecticide resistance amongst malaria vectors may render vector control interventions ineffective if not properly addressed. This may lead to increased malaria cases in provinces with ongoing transmission and may render provinces under in elimination phase and those earlier declared malaria-free at risk of reintroduction and/or re-establishment. Since several provinces continue to report imported cases from continue reading : Boosting Malaria Vector Control by Addressing Insecticide Resistance
‘Nudging’, defined as altering the environmental context in which a decision is made or a certain behavior is enacted, has shown promising results in several health promotion strategies. Read on to learn how the nudging technique can increase vaccine confidence.
The Integrated Management of Childhood Illness (IMCI) is a global strategy to reduce morbidity, mortality, disability and promote growth and development of infants and children under five years old. The Philippines implemented IMCI in 1996. Read more to learn how the IMCI project can be improved.
The 2018 Philippine Tuberculosis (TB) Drug Resistance Survey is the latest among a series of periodic nationwide surveillance activities spearheaded by the National Tuberculosis Reference Laboratory (NTRL). These surveys aim to measure the prevalence of drug-resistance in bacteriologically conﬁrmed cases. The previous survey in 2021 found that the prevalence of multidrug-resistant tuberculosis (MDR-TB) was at continue reading : Strengthening Surveillance of Drug-Resistant Tuberculosis (TB)